Trials / Completed
CompletedNCT01104012
Validation of Proteomic Analyses for Allergic Asthma and Rhinitis
The VAPARA Study: Validation of Proteomic Analyses for Allergic Asthma and Rhinitis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 133 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Nīmes · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to verify and validate the intrinsic diagnostic value in terms of sensitivity and specificity of proteomic profiles determined during a pre-study for discriminating between allergy related asthma and allergy related rhinitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Classification as "asthmatic" or "rhinitis only" via proteomic analysis | Proteomic profiles are established for each patient using plasma and serum samples |
| BIOLOGICAL | Classification as "asthmatic" or "rhinitis only" according to a metacholine test | A positive metacholine test indicating bronchial hyperresponsiveness is currently our Gold Standard for diagnosing asthma. |
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2012-10-01
- Completion
- 2012-10-01
- First posted
- 2010-04-15
- Last updated
- 2015-03-27
Locations
3 sites across 1 country: France
Source: ClinicalTrials.gov record NCT01104012. Inclusion in this directory is not an endorsement.